LAWRENCE, Mass., Oct. 5, 2011 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM) is a leading manufacturer of innovative dialysis products and together with its patients and their care partners is leading the home hemodialysis revolution. Because of their passion and enthusiasm, NxStageUsers, together with thousands of other patients, continue to fuel the growth of NxStage by helping to change the dialysis treatment paradigm and give dialysis patients greater access to quality care, including more frequent hemodialysis with the NxStage System One™.
The Second Annual NxStageUsers Group Meet-Up and Conference is being held from October 2nd to 5th in New Orleans. The event, "Patient-Centered Dialysis: You're in the Drivers Seat!" is host to numerous speakers, including prominent nephrologists, dialyzors, care partners, and industry leaders. NxStageUsers is an independent patient advocacy organization that is not affiliated with NxStage Medical, Inc.
"NxStageUsers appreciates all that NxStage Medical has done and is doing to reinvent home dialysis and allow people to be rehabilitated as was the original mandate of the Medicare program for kidney failure," said Rich Berkowitz, President and Founder of NxStageUsers. "Meet-ups like this empower us to further spread the word of the positive impact of home hemodialysis therapy. We look forward to future years of meet-ups and conferences under our new expanded banner of Home Dialyzors United."
"It is truly amazing to see our patients and their families independently gather and host a growing conference dedicated to advancing the quality of care of home hemodialysis patients," said Joe Turk, President, North America of NxStage. "Our patients have told us that with the freedom to dialyze when and where they want, they feel better, they spend more quality time with family and friends, they travel, and they go back to work. We thank NxStageUsers for championing awareness of the benefits of home hemodialysis, and for giving NxStage the opportunity to participate and speak at this energizing event."
About the NxStage System One
The NxStage System One is the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration (FDA). Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy. When combined with the NxStage Pureflow SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid on demand. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs, at home or on vacation.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. NxStage is leading the development of the home hemodialysis market in the US with the only portable hemodialysis machine, the System One, cleared for home use by the FDA. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com/.
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond NxStage's control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance or achievements including market acceptance and demand for NxStage's System One, growth in home hemodialysis, and certain other factors that may affect future operating results and which are detailed in NxStage's filings with the Securities and Exchange Commission, including Quarterly Report on Form 10Q for the quarter ended June 30, 2011.
In addition, the statements in this press release represent NxStage's expectations and beliefs as of the date of this press release. NxStage anticipates that subsequent events and developments may cause these expectations and beliefs to change. However, while NxStage may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so, whether as a result of new information, future events, or otherwise. These forward-looking statements should not be relied upon as representing NxStage's expectations or beliefs as of any date subsequent to the date of this press release.
Kristen Sheppard, Esq.
Vice President, Investor Relations
NxStage Medical, Inc.
|SOURCE NxStage Medical, Inc.|
Copyright©2010 PR Newswire.
All rights reserved